Votrient (pazopanib) treatment for advanced renal cell carcinoma (kidney cancer) and metastatic soft tissue sarcoma. Kidney cancer can cause problems with uncontrolled cell growth and the development of new blood vessels that supply the tumor. Soft tissue sarcomaa is a type of cancer which affects the supportive tissue of the body. Pazopanib works by blocking certain enzymes in the body called tyrosine kinases inhibitor that are responsible for causing the cancer cells to grow and multiply. The votrient tablets should be taken once daily without food (at least 1 hour before or 2 hours after a meal).
For more please visit : http://www.healthcare247.co/